Accelerated partial breast irradiation trials: Diversity in rationale and design

Radiotherapy and Oncology

Volumn 91, Issue 1, 2009, Pages 16-22

  Mannino, Mariella ^a   Yarnold, John ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Accelerated partial breast irradiation; Breast cancer; Randomised trials

Indexed keywords

BALLOON CATHETER; BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG DOSE REGIMEN; HUMAN; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RELATIVE BIOLOGIC EFFECTIVENESS; RETROSPECTIVE STUDY; REVIEW; SEGMENTAL MASTECTOMY; TELETHERAPY; TUMOR LOCALIZATION;

BRACHYTHERAPY; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 62549111698     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.12.011     Document Type: Review

References (56)

1. Offersen B.V., Overgaard M., Kroman N., and Overgaard J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 90 (2009) 1-13
2. Orecchia R., Ciocca M., Lazzari R., et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 12 (2003) 483-490
3. Vaidya JS, Baum M, Tobias JS, Houghton J. Lancet. Targeted intraoperative radiotherapy; 1999. Available from: http://www.thelancet.com/journals/lancet/misc/protocol/99PRT-47.
4. Strnad V, Polgar C. On behalf of the European Brachytherapy Breast Cancer GEC-ESTRO Working Group. GEC-ESTRO APBI Trial: Interstitial brachytherapy alone versus external beam radiation therapy after breast conserving surgery for low risk invasive carcinoma and low risk duct carcinoma in-situ (DCIS) of the female breast; 2006. Available from: http://www.apbi.uni-erlangen.de/outline/outline.html.
5. Wolmark N, Curran WJ. On behalf of NSABP and RTOG of the American College of Radiology (ACR). NSABP Protocol B-39. RTOG Protocol 0413. A randomized phase III study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. National surgical adjuvant breast and bowel project (NSABP). Trial protocol March 13, 2007. p. 1-132.
6. OCOG. Ontario Clinical Oncology Group (OCOG), Canadian Institutes of Health Research (CIHR), Canadian Breast Cancer Research Alliance. RAPID: Randomized Trial of Accelerated Partial Breast Irradiation; 2008. Available from: http://clinicaltrials.gov/ct2/show/NCT00282035.
7. Yarnold J, Coles C. On behalf of the IMPORT LOW Trial Management Group: Intensity Modulated and Partial Organ Radiotherapy. Randomised trial testing intensity modulated and partial organ radiotherapy following breast conservation surgery for early breast cancer. Trial Protocol, version 4. Sutton, Surrey, UK: The Institute of Cancer Research, Royal Cancer Hospital; 2008. p. 1-74.
8. Vaidya J.S., Tobias J.S., Baum M., et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol 15 (2005) 84-91
9. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 (2001) 997-1003
10. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
11. Vaidya JS. A novel approach for local treatment of breast cancer. University of London; 2001. p. 236. Available from: http://www.personal.dundee.ac.uk/jsvaidya/papers/cvjsv.htm.
12. Vaidya J.S., Vyas J.J., Chinoy R.F., Merchant N., Sharma O.P., and Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 74 (1996) 820-824
13. Deng G., Lu Y., Zlotnikov G., Thor A.D., and Smith H.S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274 (1996) 2057-2059
14. Veronesi U., Orecchia R., Luini A., et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37 (2001) 2178-2183
15. Brenner D.J., Leu C.S., Beatty J.F., and Shefer R.E. Clinical relative biological effectiveness of low-energy X-rays emitted by miniature X-ray devices. Phys Med Biol 44 (1999) 323-333
16. Strnad V., Ott O., Potter R., et al. Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. Brachytherapy 3 (2004) 115-119
17. Polgar C., Sulyok Z., Fodor J., et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80 (2002) 121-128 discussion 129
18. Vicini F.A., Kestin L.L., and Goldstein N.S. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys 60 (2004) 722-730
19. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003) 289-293
20. Vicini F.A., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57 (2003) 1247-1253
21. Available from: http://groups.eortc.be/radio/res/irma/synopsis_trial_irma1.pdf.
22. Coles C., and Yarnold J. The IMPORT trials are launched (September 2006). Clin Oncol (R Coll Radiol) 18 (2006) 587-590
23. Suwinski R., and Withers H.R. Time factor and treatment strategies in subclinical disease. Int J Radiat Biol 79 (2003) 495-502
24. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9 (2008) 331-341
25. Fisher E.R., Sass R., Fisher B., Gregorio R., Brown R., and Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57 (1986) 1717-1724
26. Liljegren G., Holmberg L., Bergh J., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17 (1999) 2326-2333
27. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 (1996) 1659-1664
28. Malmstrom P., Holmberg L., Anderson H., et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 39 (2003) 1690-1697
29. Kurtz J.M., Amalric R., Brandone H., et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 63 (1989) 1912-1917
30. Recht A., Silen W., Schnitt S.J., et al. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys 15 (1988) 255-261
31. Veronesi U., Marubini E., Del Vecchio M., et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87 (1995) 19-27
32. Smith T.E., Lee D., Turner B.C., Carter D., and Haffty B.G. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48 (2000) 1281-1289
33. Huang E., Buchholz T.A., Meric F., et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95 (2002) 2059-2067
34. Freedman G.M., Anderson P.R., Hanlon A.L., Eisenberg D.F., and Nicolaou N. Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 61 (2005) 1328-1336
35. Krauss D.J., Kestin L.L., Mitchell C., Martinez A.A., and Vicini F.A. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys 60 (2004) 731-740
36. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
37. Holland R., Veling S.H., Mravunac M., and Hendriks J.H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
38. Goldstein N.S., Kestin L.J., and Vicini F.A. Monomorphic epithelial proliferations: characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. Am J Clin Pathol 128 (2007) 1023-1034
39. Li Z., Moore D.H., Meng Z.H., Ljung B.M., Gray J.W., and Dairkee S.H. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Cancer Res 62 (2002) 1000-1003
40. Lakhani S.R., Chaggar R., Davies S., et al. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol 189 (1999) 496-503
41. Fowble B., Solin L.J., Schultz D.J., Rubenstein J., and Goodman R.L. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19 (1990) 833-842
42. Komoike Y., Akiyama F., Iino Y., et al. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 12 (2005) 104-111
43. Going J.J., and Moffat D.F. Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol 203 (2004) 538-544
44. Ohtake T., Abe R., Kimijima I., et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 76 (1995) 32-45
45. Love S.M., and Barsky S.H. Breast-duct endoscopy to study stages of cancerous breast disease. Lancet 348 (1996) 997-999
46. Dooley W.C. Routine operative breast endoscopy during lumpectomy. Ann Surg Oncol 10 (2003) 38-42
47. Middleton L.P., Vlastos G., Mirza N.Q., Eva S., and Sahin A.A. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer 94 (2002) 1910-1916
48. Vicini F.A., Antonucci J.V., Goldstein N., et al. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy. Cancer 109 (2007) 1264-1272
49. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
50. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348 (1996) 708-713
51. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 (2002) 4141-4149
52. Winzer K.J., Sauer R., Sauerbrei W., et al. Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 40 (2004) 998-1005
53. Potter R., Gnant M., Kwasny W., et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 68 (2007) 334-340
54. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
55. Mannino M., and Yarnold J.R. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?. Radiother Oncol 90 (2009) 14-22
56. Dr. Boon Chua, Personal Communication.